Corrigendum: A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients (Frontiers in Oncology, (2024), 14, (1463805), 10.3389/fonc.2024.1463805)

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

In the published article, there was an error. The main text contains an inconsistency with the data presented in Table 1. A correction has been made to Results, Comparison of baseline characteristics between declined HRV group and normal HRV group, Paragraph 1. This sentence previously stated: “The proportions of stage I, stage II, stage III, and stage IV were 1.5%, 8.4%, 55.0%, and 35.1%, respectively.” The corrected sentence appears below: “The proportions of stage I, stage II, stage III, and stage IV were 6.1%, 8.4%, 53.4%, and 32.1%, respectively.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Cite

CITATION STYLE

APA

Zhang, L., Liu, Y., Han, D., Wang, Y., Geng, F., Ding, W., & Zhang, X. (2025). Corrigendum: A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients (Frontiers in Oncology, (2024), 14, (1463805), 10.3389/fonc.2024.1463805). Frontiers in Oncology. Frontiers Media SA. https://doi.org/10.3389/fonc.2025.1566535

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free